Neeloffer Mookherjee Selected Research

NF-kappa B (NF-kB)

2/2006

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Neeloffer Mookherjee Research Topics

Disease

24	Inflammation (Inflammations) 01/2024 - 02/2006
14	Infections 01/2020 - 01/2006
11	Asthma (Bronchial Asthma) 01/2024 - 01/2016
8	Rheumatoid Arthritis 01/2023 - 09/2011
6	Arthritis (Polyarthritis) 01/2023 - 08/2011
5	Experimental Arthritis 01/2023 - 02/2014
3	Respiratory Tract Diseases (Respiratory Tract Disease) 12/2022 - 12/2020
3	Respiratory Hypersensitivity 01/2021 - 01/2016
3	Communicable Diseases (Infectious Diseases) 01/2020 - 01/2012
3	Sepsis (Septicemia) 08/2007 - 01/2006
2	Muscle Cramp (Cramp) 01/2023 - 01/2020
2	Pain (Aches) 01/2021 - 01/2017
2	Bacterial Infections (Bacterial Infection) 08/2009 - 08/2007
1	Airway Remodeling 01/2024
1	Atherosclerosis 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Necrosis 10/2018
1	Disease Progression 01/2017
1	Pneumonia (Pneumonitis) 01/2016
1	Hyperplasia 01/2016
1	Septic Shock (Toxic Shock Syndrome) 05/2015
1	Tuberculosis (Tuberculoses) 01/2015
1	Autoimmune Diseases (Autoimmune Disease) 12/2013
1	Chronic Disease (Chronic Diseases) 01/2012
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 08/2007
1	Endotoxemia 02/2006

Drug/Important Bio-Agent (IBA)

18	Peptides (Polypeptides)IBA 03/2024 - 01/2006
9	CytokinesIBA 12/2023 - 08/2011
8	CathelicidinsIBA 01/2023 - 02/2006
6	Proteins (Proteins, Gene)FDA Link 12/2022 - 02/2006
4	Antimicrobial Cationic PeptidesIBA 01/2024 - 02/2006
4	Interleukin-33IBA 12/2023 - 01/2016
4	AllergensIBA 12/2022 - 01/2020
4	Vitamin D FDA LinkGeneric 01/2021 - 01/2012
4	IDR 1002IBA 01/2021 - 08/2011
3	SteroidsIBA 12/2023 - 10/2018
3	InterleukinsIBA 12/2022 - 08/2011
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
3	Antimicrobial PeptidesIBA 01/2020 - 08/2018
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2015 - 01/2006
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2023 - 01/2020
2	CurcuminIBA 01/2023 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022 - 02/2006
2	ChemokinesIBA 12/2022 - 02/2006
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2016
2	ProteomeIBA 01/2022 - 01/2021
2	AcidsIBA 01/2021 - 08/2011
2	DefensinsIBA 01/2020 - 10/2019
2	hydroxide ionIBA 01/2019 - 01/2015
2	MicroRNAs (MicroRNA)IBA 11/2017 - 12/2013
2	EndotoxinsIBA 05/2015 - 09/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2024
1	chemotactic factor inactivatorIBA 12/2023
1	AlarminsIBA 12/2023
1	Vehicle Emissions (Emissions, Vehicle)IBA 01/2023
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2023
1	Methacholine Chloride (Methacholine)FDA Link 01/2023
1	Apolipoproteins B (ApoB)IBA 01/2022
1	Chemokine CX3CL1IBA 01/2022
1	Cholecalciferol (Vitamin D3)FDA Link 01/2021
1	GlucocorticoidsIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 11/2020
1	LipopolysaccharidesIBA 01/2020
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2019
1	Interferon-gamma (Interferon, gamma)IBA 10/2018
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2018
1	Buprenorphine (Subutex)FDA LinkGeneric 01/2017
1	EnzymesIBA 01/2017
1	AntioxidantsIBA 01/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	Analgesics (Analgesic Drugs)IBA 01/2017
1	Immunoglobulin G (IgG)IBA 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	Interleukin-5 (Interleukin 5)IBA 01/2016
1	Interleukin-13IBA 01/2016
1	Immunoglobulin E (IgE)IBA 01/2016
1	CollagenIBA 01/2016
1	AminoglycosidesIBA 05/2015
1	Dual Specificity Phosphatase 1IBA 09/2014
1	Peptide Hydrolases (Proteases)FDA Link 01/2013
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2012
1	Vitamin D-Binding ProteinIBA 01/2012
1	Vancomycin FDA LinkGeneric 04/2007
1	Toll-Like Receptor AgonistsIBA 02/2006
1	NF-kappa B (NF-kB)IBA 02/2006

Therapy/Procedure

7	Therapeutics 12/2022 - 08/2007
1	Oral Administration 01/2023
1	Immunomodulation 01/2021